Tarsus Pharmaceuticals, Inc. — SCHEDULE 13G/A Filings
7 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Tarsus Pharmaceuticals, Inc. (TARS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tarsus Pharmaceuticals, Inc. has filed 7 SCHEDULE 13G/A documents with the SEC since 2020. To view all SEC filings by Tarsus Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002452 | Mar 27, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-002025 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004834 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021710 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-007881 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001558 | Apr 24, 2025 | — |
| SCHEDULE 13G/A | — | 0001085146-25-001215 | Feb 13, 2025 | — |